Otsuka Holdings Co. Ltd. ADR | |
Stock Exchange | Other OTC |
EPS |
$0.65 |
Market Cap |
$19.34 B |
Shares Outstanding |
1.12 B |
Public Float |
- |
Otsuka Holdings Co. Ltd. | |
Stock Exchange | Other OTC |
EPS |
$1.29 |
Market Cap |
$19.64 B |
Shares Outstanding |
- |
Public Float |
- |
Otsuka Holdings Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY142.41 |
Market Cap |
JPY2.1 T |
Shares Outstanding |
557.84 M |
Public Float |
388.56 M |
Address |
Shinagawa Grand Central Tower, 12/F Tokyo Tokyo 108 Japan |
Employees | - |
Website | http://www.otsuka.com |
Updated | 07/08/2019 |
Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following businesses: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals business manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. |